Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-07-27 07:40 |
Pharming Reports on Financial Results for the First Half of 2017
|
English | 228.9 KB | ||
| 2017-07-26 07:28 |
Pharming announces publication of RUCONEST® prophylactic data in The Lancet
|
English | 144.7 KB | ||
| 2017-07-21 07:59 |
Pharming announces completion of its refinancing with a single US$100 million d…
|
English | 482.2 KB | ||
| 2017-05-25 08:22 |
Pharming Reports On Annual General Meeting Of Shareholders
|
English | 132.1 KB | ||
| 2017-05-17 16:53 |
Pharming Announces Withdrawal of Agenda Items Related to Amendment of the Artic…
|
English | 358.6 KB | ||
| 2017-05-17 07:27 |
Interim Report on Financial Results for the First Quarter 2017
|
English | 706.9 KB | ||
| 2017-05-16 11:33 |
A global awareness day for a rare life-threatening condition: World HAEday, 16t…
|
English | 406.7 KB | ||
| 2017-05-16 07:36 |
Pharming announces refinancing of its existing debt by a single US$100 million …
|
English | 492.8 KB | ||
| 2017-04-12 08:53 |
Aankondiging AVA Pharming Group N.V. en publicatie AVA-stukken
|
Dutch | 364.4 KB | ||
| 2017-04-12 08:53 |
Aankondiging AVA Pharming Group N.V. en publicatie AVA-stukken
|
Dutch | 345.1 KB | ||
| 2017-03-23 09:02 | English | 4.6 MB | |||
| 2017-03-09 07:51 |
Pharming Group Reports on Preliminary Financial Results for 2016
|
English | 187.6 KB | ||
| 2017-01-26 08:57 |
Pharming announces issue of new stock as a result of conversion of Amortizing B…
|
English | 134.8 KB | ||
| 2017-01-16 08:31 |
European Commission amends Marketing Authorisation for RUCONEST® to include sel…
|
English | 457.8 KB | ||
| 2016-12-08 07:42 |
Pharming announces completion of acquisition of all North American commercialis…
|
English | 146.7 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
